Vector Bioscience Cambridge
PrivateLast Round
Series A
May 21, 2025
Total Funding Raised
$3.26M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Vector Bioscience Cambridge is a biotechnology company developing a machine-learning empowered drug delivery platform using nanoshuttle technology for the targeted release of therapeutics in oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Advanced Materials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vector Bioscience Cambridge Comparables
Compare Vector Bioscience Cambridge with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NaDeNo Nanoscience | 79% | |
| Optimeos Life Sciences | 77% | |
| Hone Bio | 77% | |
Vector Bioscience Cambridge Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 21, 2025 | ||||
| Grant | Mar 1, 2023 | ||||
| Accelerator | Jun 16, 2022 |
Key People
Founding team and executive leadership
Vector Bioscience Cambridge Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Innovate UK | Grant |
| Cambridge Enterprise | Accelerator, Grant |
| Endless Frontier Labs | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 107% MoM, reaching 1.9K.
- Jan 14, 2025
Monthly visitors grew 40% MoM.
Vector Bioscience Cambridge Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vector Bioscience Cambridge's valuation, stock price, and market status.